Literature DB >> 23386313

Comparison of biventricular dimensions and function between pediatric sickle-cell disease and thalassemia major patients without cardiac iron.

Antonella Meloni1, Jon Detterich, Vasili Berdoukas, Alessia Pepe, Massimo Lombardi, Thomas D Coates, John C Wood.   

Abstract

Patients with chronic anemia develop compensatory ventricular dilation, even when maintained on chronic transfusion regimens. It is important to characterize these effects to interpret pathological changes in cardiac dimensions and function introduced by iron overload and sickle cell vasculopathy. Our primary goal was to compare biventricular dimensions and function assessed by cardiovascular magnetic resonance (CMR) in pediatric, chronically-transfused sickle-cell disease (SCD) and thalassemia major (TM) patients who had normal cardiac iron levels. Moreover, we explored systematic sex differences in ventricular dimensions in both populations. We identified 261 studies suitable for analysis from 64 patients with SCD (34 females) and 49 patients with TM (20 females). All demographic and CMR parameters were inversely weighted by the number of exams. In both populations, males had larger left and right ventricular dimensions than females, with a more marked effect observed in patients with SCD. Compared to patients with TM, patients with SCD showed significantly greater biventricular dilation and left ventricular hypertrophy. This difference could not be explained by different hemoglobin levels, cardiac iron overload, and systolic blood pressure. The left ventricular (LV) ejection fraction (EF) for the males and the right ventricular (RV) EF for both the sexes were comparable between SCD and TM groups, while females with SCD had significantly lower LV EF than females with TM. Our results represent important baseline findings that place changes introduced by iron overload as well as systemic and pulmonary vasculopathy in proper context.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23386313      PMCID: PMC6903699          DOI: 10.1002/ajh.23376

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  39 in total

1.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.

Authors:  L J Anderson; S Holden; B Davis; E Prescott; C C Charrier; N H Bunce; D N Firmin; B Wonke; J Porter; J M Walker; D J Pennell
Journal:  Eur Heart J       Date:  2001-12       Impact factor: 29.983

2.  Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease.

Authors:  John C Wood; J Michael Tyszka; Susan Carson; Marvin D Nelson; Thomas D Coates
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

3.  A correlation of clinical and hemodynamic studies in patients with mild and severe anemia with and without congestive failure.

Authors:  J S GRAETTINGER; R L PARSONS; J A CAMPBELL
Journal:  Ann Intern Med       Date:  1963-04       Impact factor: 25.391

4.  MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients.

Authors:  John C Wood; Cathleen Enriquez; Nilesh Ghugre; J Michael Tyzka; Susan Carson; Marvin D Nelson; Thomas D Coates
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

5.  Normalized left ventricular volumes and function in thalassemia major patients with normal myocardial iron.

Authors:  Mark A Westwood; Lisa J Anderson; Alicia M Maceira; Farrukh T Shah; Emma Prescott; John B Porter; Beatrix Wonke; J Malcolm Walker; Dudley J Pennell
Journal:  J Magn Reson Imaging       Date:  2007-06       Impact factor: 4.813

6.  Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia.

Authors:  Dudley J Pennell; John B Porter; Maria Domenica Cappellini; Amal El-Beshlawy; Lee Lee Chan; Yesim Aydinok; Mohsen Saleh Elalfy; Pranee Sutcharitchan; Chi-Kong Li; Hishamshah Ibrahim; Vip Viprakasit; Antonis Kattamis; Gillian Smith; Dany Habr; Gabor Domokos; Bernard Roubert; Ali Taher
Journal:  Blood       Date:  2009-12-08       Impact factor: 22.113

Review 7.  The thalassaemias.

Authors:  D J Weatherall
Journal:  BMJ       Date:  1997-06-07

8.  Left ventricular hypertrophy and diastolic dysfunction in children with sickle cell disease are related to asleep and waking oxygen desaturation.

Authors:  Mark C Johnson; Fenella J Kirkham; Susan Redline; Carol L Rosen; Yan Yan; Irene Roberts; Jeanine Gruenwald; Jan Marek; Michael R DeBaun
Journal:  Blood       Date:  2010-04-08       Impact factor: 22.113

9.  Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance.

Authors:  N G Bellenger; L C Davies; J M Francis; A J Coats; D J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2000       Impact factor: 5.364

10.  Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort.

Authors:  Carol J Salton; Michael L Chuang; Christopher J O'Donnell; Michelle J Kupka; Martin G Larson; Kraig V Kissinger; Robert R Edelman; Daniel Levy; Warren J Manning
Journal:  J Am Coll Cardiol       Date:  2002-03-20       Impact factor: 24.094

View more
  4 in total

1.  Evaluation of tissue doppler echocardiography and T2* magnetic resonance imaging in iron load of patients with thalassemia major.

Authors:  Mehrdad Saravi; Ahmad Tamadoni; Rozita Jalalian; Hassan Mahmoodi-Nesheli; Mosatafa Hojati; Saeed Ramezani
Journal:  Caspian J Intern Med       Date:  2013

2.  Pulmonary hypertension in well-transfused thalassemia major patients.

Authors:  Antonella Meloni; Jon Detterich; Alessia Pepe; Paul Harmatz; Tom D Coates; John C Wood
Journal:  Blood Cells Mol Dis       Date:  2014-11-24       Impact factor: 3.039

Review 3.  Mechanisms linking red blood cell disorders and cardiovascular diseases.

Authors:  Ioana Mozos
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

4.  Use of Mobile Health Apps and Wearable Technology to Assess Changes and Predict Pain During Treatment of Acute Pain in Sickle Cell Disease: Feasibility Study.

Authors:  Amanda Johnson; Fan Yang; Siddharth Gollarahalli; Tanvi Banerjee; Daniel Abrams; Jude Jonassaint; Charles Jonassaint; Nirmish Shah
Journal:  JMIR Mhealth Uhealth       Date:  2019-12-02       Impact factor: 4.773

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.